2020 ASCO Virtual Direct™ Highlights

 

2020 ASCO Virtual Direct™ Highlights
S

2020 ASCO Update on Recurrent Ovarian Cancer: Who Should Have a Secondary Cytoreduction?

By 2020 ASCO Virtual Direct™ Highlights FEATURING Sarah Temkin
By 2020 ASCO Virtual Direct™ Highlights FEATURING Sarah Temkin
0 views
July 16, 2020
Comments 0
Login to view comments. Click here to Login

Featured Video

06:14
Lilly Medical Affairs

CDK4/6 Inhibitors as First-Line Treatment for HR+, HER2- MBC

Feat. J. O’Shaughnessy

Featured Video

23:35
University of Colorado Division of Hematology

2024 Updates in PV/ET

Feat. B. McMahon
GYN
14:29
2020 ASCO Virtual Direct™ Highlights

2020 ASCO Update on Recurrent Ovarian Cancer: Who Should Have a Seco…

Feat. S. Temkin
15:50
2020 ASCO Virtual Direct™ Highlights

2020 ASCO Update on PARPi in Ovarian Cancer: Is BRCA Related to Ther…

Feat. S. Temkin
08:11
2020 ASCO Virtual Direct™ Highlights

2020 ASCO Update: What Is the Long-term Oncological Safety of SNL Bi…

Feat. S. Temkin